Dental and Medical Office iMET to Reduce Teen Tobacco, Alcohol, and Drug Use

Sponsor

Boston Children's Hospital (Other)

Overall Status

Completed

CT.gov ID

NCT00907309

Collaborator

Cambridge Health Alliance (Other), Tufts Medical Center (Other), Harvard School of Dental Medicine (Other), Fallon Clinic (Industry)

121

Enrollment

Location

Arms

Duration (Months)

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The purpose of the project is to improve adolescent behavioral counseling services in healthcare settings with a new Internet/Intranet-based Motivational Enhancement Therapy (iMET) intervention that targets the use of tobacco, alcohol, and other drugs.

Condition or Disease	Intervention/Treatment	Phase
Use; Tobacco, Harmful Alcohol Abuse Drug Abuse	Behavioral: iMET Behavioral: iMET/TE	Phase 1/Phase 2

Detailed Description

We have previously developed and tested in a treatment population a promising MET program for alcohol and drug use. We will broaden the MET intervention to also target tobacco use and convert the new materials into a self-administered format.

Study Design

Study Type:

Interventional

Actual Enrollment :

121 participants

Allocation:

Randomized

Intervention Model:

Parallel Assignment

Masking:

None (Open Label)

Primary Purpose:

Treatment

Official Title:

Dental and Medical Office Internet/Intranet Motivational Enhancement Therapy to Reduce Teen Tobacco, Alcohol, and Drug Use

Study Start Date :

Sep 1, 2010

Actual Primary Completion Date :

Sep 1, 2012

Actual Study Completion Date :

Sep 1, 2012

Arms and Interventions

Arm	Intervention/Treatment
No Intervention: Treatment as usual Participants will receive treatment as usual from their provider.
Experimental: iMET Participants will receive the iMET intervention.	Behavioral: iMET Participants will receive the iMET intervention
Experimental: iMET/TE Participants will receive the iMET intervention and Technological Extenders (TEs).	Behavioral: iMET/TE Participants will receive the iMET intervention and also receive TEs (Technological Extenders)

Arm

Intervention/Treatment

No Intervention: Treatment as usual

Participants will receive treatment as usual from their provider.

Experimental: iMET

Participants will receive the iMET intervention.

Behavioral: iMET

Participants will receive the iMET intervention

Experimental: iMET/TE

Participants will receive the iMET intervention and Technological Extenders (TEs).

Behavioral: iMET/TE

Participants will receive the iMET intervention and also receive TEs (Technological Extenders)

Outcome Measures

Primary Outcome Measures

Frequency of tobacco, alcohol, marijuana, and other drug use [3 months, 6 months]

Secondary Outcome Measures

Rates of initiation and cessation of tobacco, alcohol, marijuana and other drug use [3 months, 6 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:

12 Years to 21 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

12-21 years old
Coming for routine care

Exclusion Criteria:

Medically or emotionally unstable day of visit
Already receiving behavioral health services
Cannot read/understand English
Will not be available for post-tests

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Children's Hospital Boston	Boston	Massachusetts	United States	02115

Sponsors and Collaborators

Boston Children's Hospital
Cambridge Health Alliance
Tufts Medical Center
Harvard School of Dental Medicine
Fallon Clinic

Investigators

Principal Investigator: John R. Knight, MD, Boston Children's Hospital

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

web site of Center for Adolescent Substance Abuse Research at Children's Hospital Boston

Publications

None provided.

Responsible Party:

John R Knight, MD, Associate Professor of Pediatrics, Harvard Medical School; Senior Associate in Medicine; Associate in Psychiatry, Director, Center for Adolescent Substance Abuse Research, Boston Children's Hospital, Boston Children's Hospital

ClinicalTrials.gov Identifier:

NCT00907309

Other Study ID Numbers:

iMET RFA-OD-09-003

First Posted:

May 22, 2009

Last Update Posted:

Oct 7, 2016

Last Verified:

Oct 1, 2016

Keywords provided by John R Knight, MD, Associate Professor of Pediatrics, Harvard Medical School; Senior Associate in Medicine; Associate in Psychiatry, Director, Center for Adolescent Substance Abuse Research, Boston Children's Hospital, Boston Children's Hospital

Additional relevant MeSH terms:

Alcoholism

Substance-Related Disorders

Study Results

No Results Posted as of Oct 7, 2016